Apellis Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 574 | 0.0% | 22,852 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 380 | 0.0% | 21,973 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 545 | 0.0% | 24,937 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 1,688 | 0.0% | 52,897 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 1,766 | 0.0% | 61,221 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 2,805 | 0.0% | 73,135 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 7,249 | 0.0% | 123,330 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 6,345 | 0.0% | 106,002 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 2,064 | 0.0% | 54,265 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 15,457 | 0.0% | 169,673 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 9,010 | 0.0% | 136,596 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 4,275 | 0.0% | 82,830 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 6,193 | 0.0% | 93,084 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 4,379 | 0.0% | 96,876 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 5,002 | 0.0% | 100,299 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 1,715 | 0.0% | 35,949 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 1,121 | 0.0% | 34,024 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 2,323 | 0.0% | 36,757 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 1,468 | 0.0% | 34,216 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 2,075 | 0.0% | 36,278 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 1,066 | 0.0% | 35,338 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 1,107 | 0.0% | 35,973 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 958 | 0.0% | 35,742 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 905 | 0.0% | 29,551 | 12/31/2019 |